Cellumed Co. Ltd (049180) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Based on the latest financial reports, Cellumed Co. Ltd (049180) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-294.63 Million ≈ $-199.67K USD) by net assets (₩16.52 Billion ≈ $11.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cellumed Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Cellumed Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 049180 total debt and obligations for a breakdown of total debt and financial obligations.

Cellumed Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cellumed Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Korea Eng Cons KO:023350	-0.188x
HP Adhesives Limited NSE:HPAL	0.012x
Athanase Innovation AB ST:ATIN	-0.037x
Latrobe Magnesium Ltd AU:LMG	-0.021x
Eastern Star Real Estate Public Company Limited BK:ESTAR	0.151x
Lien Chang Electronic Enterprise Co Ltd TW:2431	-0.008x
Moonbae Steel KO:008420	-0.026x
Panjawattana Plastic Public Company Limited BK:PJW	0.105x

Annual Cash Flow Conversion Efficiency for Cellumed Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Cellumed Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 049180 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩8.78 Billion ≈ $5.95 Million	₩-418.53 Million ≈ $-283.63K	-0.048x	+79.65%
2023-12-31	₩23.02 Billion ≈ $15.60 Million	₩-5.40 Billion ≈ $-3.66 Million	-0.234x	-48.97%
2022-12-31	₩53.94 Billion ≈ $36.56 Million	₩-8.49 Billion ≈ $-5.75 Million	-0.157x	+30.01%
2021-12-31	₩47.99 Billion ≈ $32.52 Million	₩-10.79 Billion ≈ $-7.31 Million	-0.225x	-108.37%
2020-12-31	₩28.10 Billion ≈ $19.04 Million	₩-3.03 Billion ≈ $-2.05 Million	-0.108x	-218.21%
2019-12-31	₩5.18 Billion ≈ $3.51 Million	₩472.90 Million ≈ $320.48K	0.091x	+217.96%
2018-12-31	₩23.02 Billion ≈ $15.60 Million	₩-1.78 Billion ≈ $-1.21 Million	-0.077x	+43.15%
2017-12-31	₩37.28 Billion ≈ $25.27 Million	₩-5.07 Billion ≈ $-3.44 Million	-0.136x	-48.08%
2016-12-31	₩46.56 Billion ≈ $31.55 Million	₩-4.28 Billion ≈ $-2.90 Million	-0.092x	+17.86%
2015-12-31	₩41.27 Billion ≈ $27.97 Million	₩-4.62 Billion ≈ $-3.13 Million	-0.112x	+15.92%
2014-12-31	₩44.01 Billion ≈ $29.83 Million	₩-5.86 Billion ≈ $-3.97 Million	-0.133x	-1907.43%
2013-12-31	₩49.20 Billion ≈ $33.34 Million	₩362.28 Million ≈ $245.51K	0.007x	-15.57%
2012-12-31	₩48.75 Billion ≈ $33.04 Million	₩425.13 Million ≈ $288.10K	0.009x	-69.52%
2011-12-31	₩31.75 Billion ≈ $21.52 Million	₩908.37 Million ≈ $615.59K	0.029x	--

About Cellumed Co. Ltd

KQ:049180 Korea Medical Instruments & Supplies

Market Cap

$37.57 Million

₩55.44 Billion KRW

Market Cap Rank

#22905 Global

#1592 in Korea

Share Price

₩1009.00

Change (1 day)

-9.10%

52-Week Range

₩570.00 - ₩2570.00

All Time High

₩36700.00